1343PEfficacy and safety of lorlatinib in patients (pts)...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

1343PEfficacy and safety of lorlatinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) previously treated with 2nd-generation ALK TKIs

Felip Font, E., Shaw, A.T., Solomon, B.J., Bauer, T.M., Ou, S-H.I., Gadgeel, S., Soo, R.A., Seto, T., Clancy, J.S., James, L.P., Abbattista, A., Besse, B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx380.045
Date:
September, 2017
File:
PDF, 83 KB
english, 2017
Conversion to is in progress
Conversion to is failed